139 related articles for article (PubMed ID: 36364238)
1. Impact of
Fu J; Liu S; Tan Q; Liu Z; Qian J; Li T; Du J; Song B; Li D; Zhang L; He J; Guo K; Zhou B; Chen H; Fu S; Liu X; Cheng J; He T; Fu J
Molecules; 2022 Nov; 27(21):. PubMed ID: 36364238
[TBL] [Abstract][Full Text] [Related]
2. Prostate adenocarcinoma and COVID-19: The possible impacts of TMPRSS2 expressions in susceptibility to SARS-CoV-2.
Cheng J; Zhou J; Fu S; Fu J; Zhou B; Chen H; Fu J; Wei C
J Cell Mol Med; 2021 Apr; 25(8):4157-4165. PubMed ID: 33609069
[TBL] [Abstract][Full Text] [Related]
3. Impact of BSG/CD147 gene expression on diagnostic, prognostic and therapeutic strategies towards malignant cancers and possible susceptibility to SARS-CoV-2.
Fu J; Song B; Du J; Liu S; He J; Xiao T; Zhou B; Li D; Liu X; He T; Cheng J; Fu J
Mol Biol Rep; 2023 Mar; 50(3):2269-2281. PubMed ID: 36574092
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of two potential novel SARS-CoV-2 entries, TMPRSS2 and IFITM3, in healthy individuals and cancer patients.
Dai YJ; Zhang WN; Wang WD; He SY; Liang CC; Wang DW
Int J Biol Sci; 2020; 16(15):3028-3036. PubMed ID: 33061814
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 receptor and malignant cancers: Association of
Zhang L; Wei C; Li D; He J; Liu S; Deng H; Cheng J; Du J; Liu X; Chen H; Sun S; Yu H; Fu J
Int J Biol Sci; 2022; 18(6):2362-2371. PubMed ID: 35414771
[TBL] [Abstract][Full Text] [Related]
6. Genetic Susceptibility of ACE2 and TMPRSS2 in Six Common Cancers and Possible Impacts on COVID-19.
Hoang T; Nguyen TQ; Tran TTA
Cancer Res Treat; 2021 Jul; 53(3):650-656. PubMed ID: 33421977
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 disease and malignant cancers: The impact for the
Li D; Liu X; Zhang L; He J; Chen X; Liu S; Fu J; Fu S; Chen H; Fu J; Cheng J
Int J Biol Sci; 2021; 17(14):3954-3967. PubMed ID: 34671211
[TBL] [Abstract][Full Text] [Related]
8. Structural Basis of Covalent Inhibitory Mechanism of TMPRSS2-Related Serine Proteases by Camostat.
Sun G; Sui Y; Zhou Y; Ya J; Yuan C; Jiang L; Huang M
J Virol; 2021 Sep; 95(19):e0086121. PubMed ID: 34160253
[TBL] [Abstract][Full Text] [Related]
9. Computational analysis of TMPRSS2 expression in normal and SARS-CoV-2-infected human tissues.
Cao W; Feng Q; Wang X
Chem Biol Interact; 2021 Sep; 346():109583. PubMed ID: 34284028
[TBL] [Abstract][Full Text] [Related]
10. Decreased TMPRSS2 expression by SARS-CoV-2 predicts the poor prognosis of lung cancer patients through metabolic pathways and immune infiltration.
Liu X; Liu B; Shang Y; Cao P; Hou J; Chen F; Zhang B; Fan Y; Tan K
Aging (Albany NY); 2022 Jan; 14(1):73-108. PubMed ID: 35017320
[TBL] [Abstract][Full Text] [Related]
11.
Hu S; Hu Z; Qin J; Lin C; Jiang X
Aging (Albany NY); 2021 Jun; 13(12):15770-15784. PubMed ID: 34168096
[TBL] [Abstract][Full Text] [Related]
12. Structural Variability, Expression Profile, and Pharmacogenetic Properties of TMPRSS2 Gene as a Potential Target for COVID-19 Therapy.
Zarubin A; Stepanov V; Markov A; Kolesnikov N; Marusin A; Khitrinskaya I; Swarovskaya M; Litvinov S; Ekomasova N; Dzhaubermezov M; Maksimova N; Sukhomyasova A; Shtygasheva O; Khusnutdinova E; Radzhabov M; Kharkov V
Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33375616
[TBL] [Abstract][Full Text] [Related]
13. The Transmembrane Protease TMPRSS2 as a Therapeutic Target for COVID-19 Treatment.
Wettstein L; Kirchhoff F; Münch J
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163273
[TBL] [Abstract][Full Text] [Related]
14. Structural variations and expression profiles of the SARS-CoV-2 host invasion genes in lung cancer.
Ilikci Sagkan R; Akin-Bali DF
J Med Virol; 2020 Nov; 92(11):2637-2647. PubMed ID: 32492203
[TBL] [Abstract][Full Text] [Related]
15. Expression and Clinical Significance of SARS-CoV-2 Human Targets in Neoplastic and Non-Neoplastic Lung Tissues.
Subbarayan K; Ulagappan K; Wickenhauser C; Seliger B
Curr Cancer Drug Targets; 2021 Jul; 21(5):428-442. PubMed ID: 33292131
[TBL] [Abstract][Full Text] [Related]
16. Targeting TMPRSS2 in SARS-CoV-2 Infection.
Baughn LB; Sharma N; Elhaik E; Sekulic A; Bryce AH; Fonseca R
Mayo Clin Proc; 2020 Sep; 95(9):1989-1999. PubMed ID: 32861340
[TBL] [Abstract][Full Text] [Related]
17. Effect of DPP4/CD26 expression on SARS‑CoV‑2 susceptibility, immune response, adenosine (derivatives m
Du J; Fu J; Zhang W; Zhang L; Chen H; Cheng J; He T; Fu J
Int J Oncol; 2023 Mar; 62(3):. PubMed ID: 36799191
[TBL] [Abstract][Full Text] [Related]
18. Do Anti-androgens Have Potential as Therapeutics for COVID-19?
Mauvais-Jarvis F
Endocrinology; 2021 Aug; 162(8):. PubMed ID: 34089595
[TBL] [Abstract][Full Text] [Related]
19. Spiking dependence of SARS-CoV-2 pathogenicity on TMPRSS2.
Abbasi AZ; Kiyani DA; Hamid SM; Saalim M; Fahim A; Jalal N
J Med Virol; 2021 Jul; 93(7):4205-4218. PubMed ID: 33638460
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms and mutations of ACE2 and TMPRSS2 genes are associated with COVID-19: a systematic review.
Li J; Wang Y; Liu Y; Zhang Z; Zhai Y; Dai Y; Wu Z; Nie X; Du L
Eur J Med Res; 2022 Feb; 27(1):26. PubMed ID: 35193695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]